Rosie Mngqibisa

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 662 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study

Hans Jaeger, Edgar T. Overton, Gary Richmond et al. · The Lancet HIV · 2021 · 135 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure

Shahin Lockman, Michael D. Hughes, James McIntyre et al. · New England Journal of Medicine · 2010 · 127 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

Susan E. Krown, Carlee Moser, Patrick MacPhail et al. · The Lancet · 2020 · 91 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial

Shabir A. Madhi, Dhayendre Moodley, Sherika Hanley et al. · The Lancet HIV · 2022 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17